Your browser doesn't support javascript.
loading
Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: A prospective test negative case-control study.
Chatzilena, Anastasia; Hyams, Catherine; Challen, Rob; Marlow, Robin; King, Jade; Adegbite, David; Kinney, Jane; Clout, Madeleine; Maskell, Nick; Oliver, Jennifer; Danon, Leon; Finn, Adam.
Afiliação
  • Chatzilena A; Engineering Mathematics, University of Bristol, Bristol, UK.
  • Hyams C; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
  • Challen R; Academic Respiratory Unit, University of Bristol, UK.
  • Marlow R; Engineering Mathematics, University of Bristol, Bristol, UK.
  • King J; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
  • Adegbite D; Clinical Research and Imaging Centre, UHBW NHS Trust, Bristol, UK.
  • Kinney J; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
  • Clout M; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
  • Maskell N; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
  • Oliver J; Academic Respiratory Unit, University of Bristol, UK.
  • Danon L; Bristol Vaccine Centre, Population Health Sciences, University of Bristol, UK.
  • Finn A; Engineering Mathematics, University of Bristol, Bristol, UK.
Lancet Reg Health Eur ; 25: 100552, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36506791

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article